Clinilabs Drug Development Corporation is a global, full-service Contract Research Organization (CRO) specializing in central nervous system (CNS) drug development. With a focus on neurological disorders, substance use disorders, rare CNS disorders, and mental health disorders, Clinilabs is dedicated to bringing new therapies to patients in need. Their extensive experience, scientific knowledge, and operational expertise ensure accountability, responsibility, and integrity in every stage of the drug development process.
As the only CRO exclusively focused on CNS drug development, Clinilabs fills a significant unmet need in the pharmaceutical and biotechnology industry. From first-in-human to Phase 3 trials, they offer a complete range of services to support pharmaceutical and biotechnology companies in their quest to develop innovative treatments for patients. With a commitment to excellence and a patient-centered approach, Clinilabs is at the forefront of advancing CNS drug development.
Generated from the website